A Study of Topical Steroids as Preemptive Therapy for EGFR Inhibitor-Induced Papulopustular Eruption
NCT03115567
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
14
Enrollment
OTHER
Sponsor class
Stopped
Low enrollment accrual
Conditions
Acneiform Rash
Papulopustular Eruption
Interventions
DRUG:
Triamcinolone
Sponsor
Northwestern University